巨子 ICON - 財經股票資訊及專家分析
搜尋 股票

Atreca

BCEL
最少15分鐘延遲,股票資訊由第三方資訊供應商提供
・Atreca - 延遲價格・最後更新於 14/01 12:14
最高位
2.250
最低位
2.090
開市價
--
前收市價
2.250
成交量(千)
34.17
成交額(百萬)
0.66
買入
--
賣出
--
每手股數
--
市值(百萬)
78.39
市盈率
--
息率
--
差價
--
52週高低
20.290 - 2.050
所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

企業資料

公司名稱
Atreca
證券代碼
BCEL.US
所屬板塊
Biotechnology
公司業務
Atreca Inc is a biopharmaceutical company utilizing its differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types. The company's product candidate, ATRC-101, is a monoclonal antibody in preclinical development with a novel mechanism of action and target derived from an antibody identified using its discovery platform.
發行量
36894414
公司總部
450 East Jamie Court
公司網址
https://www.atreca.com
公司電話
+1 650 595-2595
暫無內容

關於

Atreca(BCEL.US)所屬的行業板塊為Biotechnology。
Atreca Inc is a biopharmaceutical company utilizing its differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types. The company's product candidate, ATRC-101, is a monoclonal antibody in preclinical development with a novel mechanism of action and target derived from an antibody identified using its discovery platform.
詳細公司背景可參考: https://www.atreca.com